NK cell markers predict the efficacy of IV immunoglobulins in CIDP

OBJECTIVE: To assess whether IV immunoglobulins (IVIgs) as a first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) have a regulative effect on natural killer (NK) cells that is related to clinical responsiveness to IVIg. METHODS: In a prospective longitudinal study, we co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mausberg, Anne K., Heininger, Maximilian K., Meyer Zu Horste, Gerd, Cordes, Steffen, Fleischer, Michael, Szepanowski, Fabian, Kleinschnitz, Christoph, Hartung, Hans-Peter, Kieseier, Bernd C., Stettner, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577535/
https://www.ncbi.nlm.nih.gov/pubmed/33008921
http://dx.doi.org/10.1212/NXI.0000000000000884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577535/
https://www.ncbi.nlm.nih.gov/pubmed/33008921
http://dx.doi.org/10.1212/NXI.0000000000000884

Ejemplares similares